NCT04984967

Brief Summary

Peripheral venous catheterization represents the preferential option for term or preterm infant care in order to start drug treatment or hydration, or perform anesthesia. However, the peripheral venous access is associated in approximately 50% of cases with a failure of the insertion on the first attempt in an emergency context. Using a micro-guide may facilitate the peripheral venous catheterization in newborns, by guiding the catheter in the vein and, thereby reduce the risk of transfixion of the vascular lumen.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 2, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

December 8, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

June 4, 2024

Status Verified

June 1, 2024

Enrollment Period

3 years

First QC Date

June 3, 2021

Last Update Submit

June 3, 2024

Conditions

Keywords

Newborn infantIntensive carevascular accessPeripheral intravenous catheterization

Outcome Measures

Primary Outcomes (1)

  • Success of peripheral venous catheterization at the first attempt

    The success of the placement is defined by the arrival of blood in the transparent chamber downstream of the needle during the placement, and by the absence of painful reaction and edema near the insertion site, indicating extravasation or extravascular passage, after flushing the catheter with 0.5 to 1 ml of isotonic saline. The success will be confirmed by retesting flush after securing the peripheral venous catheter in a dressing, within 3 to 5 minutes of successful puncture.

    Up to 5 minutes after the success of the placement

Secondary Outcomes (6)

  • Efficiency of the technique

    Up to 4 days.

  • Efficiency of the technique

    Up to 4 days.

  • Efficiency of the technique

    Up to 4 days.

  • Efficiency of the technique

    Up to 4 days.

  • Adverse events

    Up to 4 days.

  • +1 more secondary outcomes

Study Arms (2)

Insertion of peripheral venous catheter with micro-guide

EXPERIMENTAL
Device: Insertion of peripheral venous catheter with micro-guide

Classic insertion of peripheral venous catheter, without micro-guide

OTHER
Other: Classic insertion of peripheral venous catheter, without micro-guide

Interventions

After antisepsis, the vein is punctured using a needle. Then the micro-guide is inserted to the first landmark, which indicates the passage of the micro-guide beyond the end of the needle. After the needle removed, the peripheral venous catheter is placed on the micro-guide. The guide is then removed, the peripheral venous catheter can be used.

Insertion of peripheral venous catheter with micro-guide

After antisepsis, the catheter is introduced into the vein by a needle which is subsequently removed while the catheter remains in place.

Classic insertion of peripheral venous catheter, without micro-guide

Eligibility Criteria

AgeUp to 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Newborn admitted in the department of neonatal medicine and pediatric intensive care, at Montpellier University Hospital

You may not qualify if:

  • Term neonate \> 28 days
  • Premature neonate \> 41 weeks of corrected gestational age
  • Exclusive requirement for an umbilical venous catheter, in the context of neonatal resuscitation
  • Exclusive requirement for an epicutaneous-cava catheter, in the context of prolonged parenteral nutrition.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Montpellier

Montpellier, 34295, France

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Peripheral venous catheterization is perform by a nurse. The placement characteristics are evaluated by the investigator, blind of the condition of placement if possible.
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2021

First Posted

August 2, 2021

Study Start

December 8, 2021

Primary Completion

December 1, 2024

Study Completion

March 1, 2025

Last Updated

June 4, 2024

Record last verified: 2024-06

Locations